CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Protea Biosciences Group Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Protea Biosciences Group Inc
1311 Pineview Drive
Suite 501
Phone: (304) 292-2226p:304 292-2226 Morgantown, WV  26505-3276  United States Fax: (304) 606-3049f:304 606-3049
The Company’s Plan of Liquidation went into effect on 2/21/2020
This company is no longer actively traded on any major stock exchange.
Business Summary
Protea Biosciences Group, Inc. is a molecular information company. The Company is engaged in developing and commercializing life science technologies, products and services to identify the molecules that are produced by living cells and all life forms. It also offers a platform technology, Laser Ablation Electrospray Ionization (LAESI), which enables the direct analysis, mapping and display of molecular information in living cells and tissue samples. The Company's commercial development is centered in three business lines: Molecular Information Services, LAESI Instruments, Software and Consumables, and Molecular Diagnostics and Clinical Research. Its services enable the identification and quantitation of both small molecules (lipids and metabolites) and large molecules (proteins) and the services portfolio, inclusive of mass spectrometry imaging (MSI), proteomics, metabolomics, lipidomics and bioinformatics. Its clients include pharmaceutical, chemical and biotechnology companies.
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/201712/31/2016YesYesYes--

Industries
SIC Code Description
8731 Commercial physical and biological research
8071 Medical laboratories
3826 Laboratory analytical instruments
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Scientific Officer, Vice President - Research & Development MatthewPowell 40 1/1/2011 1/1/2011
Vice President, Secretary, Director StanleyHostler 87 1/1/2006
Independent Director Josiah T.Austin 68 1/28/2013 1/28/2013
3 additional Officers and Directors records available in full report.

Business Names
Business Name
PRGB
PRGBD
PRGBQ
Protea Biosciences, Inc.

General Information
Number of Employees: 39 (As of 12/31/2014)
Outstanding Shares: 7,941,326 (As of 10/16/2017)
Stock Exchange: OTC
Federal Tax Id: 202903252
Fax Number: (304) 606-3049


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023